Back to Stocks

VHI

VALHI INC /DE/
6 filings tracked
materialsspecialty chemicalsSMALL ($300M-2B)

Company Intelligence Hub

Filing history, signal momentum, and bull/bear evolution

Chronological Filing Evolution (Click to filter / toggle)

Thesis (Bull Case Evolution)

Valhi is successfully navigating a cyclical downturn by implementing a rigorous structural realignment at its primary subsidiary, Kronos.…

Bullish Outlook

Antithesis (Bear Case / Structural Risks)

Despite management's optimistic outlook, the first quarter of 2026 reveals deep systemic pressures within Valhi's core operations. The Chemicals segment experienced a severe margin collapse, with gross margins falling to 16% as average selling prices for TiO2 plummeted.…

Risk Factors

Read the full bull/bear analysis

You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every VHI filing.

Start Free Trial

Synthesis (Verdict & Resolution)

The Q1 2026 filing presents a company at a crossroads, balancing aggressive internal cost-cutting against a volatile global macroeconomic environment. While the top-line revenue grew slightly, the bottom line was squeezed by a combination of pricing headwinds and non-recurring tax charges. The central tension for investors lies in whether the structural cost reductions at Kronos can outpace the rising cost of raw materials and energy driven by Middle East instability. Ultimately, Valhi's ability to deliver on its 2026 growth guidance depends on the successful execution of its pricing strategy and the steady conversion of deferred real estate revenue. While the liquidity cushion remains adequate for now, the volatility in the chemicals segment and the looming maturity of subordinated debt in 2029 create a risk profile that requires close monitoring of quarterly margin trends and debt covenant compliance.

Selected Quarter

Core Takeaway

Valhi is lowering its break-even point to survive a TiO2 price dip, but geopolitical risks are driving up input costs.

Investor Lens

The trade-off is between the potential for a high-leverage recovery in chemicals and the risk of deteriorating fundamentals and legal liabilities.

Watch Next

Q2 2026 average TiO2 selling prices and the progress of the German tax appeal.

View Full SEC Report

Signal Momentum Chart

Quarterly net bull/bear signal ratio. Click nodes to select a quarter.

BULLISH (+1.0)NEUTRAL (0.0)BEARISH (-1.0)-0.20Q2 '26 (10-Q)

Signal Timeline

Active Filters:Quarter: Q2 '26 (10-Q)
bearishMay 7

Chemicals segment gross margin dropped from 22% to 16% due to lower TiO2 pricing.

margin compression
70%
bearishMay 7

Net income attributable to stockholders fell from $16.9M to $2.0M YoY.

earnings miss
60%
bullishMay 7

Management expects 2026 consolidated operating income to be higher than 2025.

guidance raise
50%
neutralMay 7

Increased use of Kronos Global Revolver to manage working capital needs.

debt restructure
30%
bearishMay 7

Chemicals segment gross margin dropped from 22% to 16% due to lower TiO2 pricing.

margin compression
70%
bearishMay 7

Net income attributable to stockholders fell from $16.9M to $2.0M YoY.

earnings miss
60%
bullishMay 7

Management expects 2026 consolidated operating income to be higher than 2025.

guidance raise
50%
neutralMay 7

Increased use of Kronos Global Revolver to manage working capital needs.

debt restructure
30%
bearishMay 7

Chemicals segment gross margin dropped from 22% to 16% due to lower TiO2 pricing.

margin compression
70%
bearishMay 7

Net income attributable to stockholders fell from $16.9M to $2.0M YoY.

earnings miss
60%
bullishMay 7

Management expects 2026 consolidated operating income to be higher than 2025.

guidance raise
50%
neutralMay 7

Increased use of Kronos Global Revolver to manage working capital needs.

debt restructure
30%
bearishMay 7

Chemicals segment gross margin dropped from 22% to 16% due to lower TiO2 pricing.

margin compression
70%
bearishMay 7

Net income attributable to stockholders fell from $16.9M to $2.0M YoY.

earnings miss
60%
bullishMay 7

Management expects 2026 consolidated operating income to be higher than 2025.

guidance raise
50%
neutralMay 7

Increased use of Kronos Global Revolver to manage working capital needs.

debt restructure
30%
bearishMay 7

Chemicals segment gross margin dropped from 22% to 16% due to lower TiO2 pricing.

margin compression
70%
bearishMay 7

Net income attributable to stockholders fell from $16.9M to $2.0M YoY.

earnings miss
60%
bullishMay 7

Management expects 2026 consolidated operating income to be higher than 2025.

guidance raise
50%
neutralMay 7

Increased use of Kronos Global Revolver to manage working capital needs.

debt restructure
30%
bearishMay 7

Chemicals segment gross margin dropped from 22% to 16% due to lower TiO2 pricing.

margin compression
70%
bearishMay 7

Net income attributable to stockholders fell from $16.9M to $2.0M YoY.

earnings miss
60%
bullishMay 7

Management expects 2026 consolidated operating income to be higher than 2025.

guidance raise
50%
neutralMay 7

Increased use of Kronos Global Revolver to manage working capital needs.

debt restructure
30%

Filing History

10-QMay 7, 2026
Expand Sequence

The Q1 2026 filing presents a company at a crossroads, balancing aggressive internal cost-cutting against a volatile global macroeconomic environment. While the top-line revenue grew slightly, the bottom line was squeezed by a combination of pricing headwinds and non-recurring tax charges. The central tension for investors lies in whether the structural cost reductions at Kronos can outpace the rising cost of raw materials and energy driven by Middle East instability. Ultimately, Valhi's ability to deliver on its 2026 growth guidance depends on the successful execution of its pricing strategy and the steady conversion of deferred real estate revenue. While the liquidity cushion remains adequate for now, the volatility in the chemicals segment and the looming maturity of subordinated debt in 2029 create a risk profile that requires close monitoring of quarterly margin trends and debt covenant compliance.

Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.